Posts in category Economic Times
Havells India shares rise 1.56 per cent in Wednesday’s trading session (03-07-2024)
The Relative Strength Index of the stock stood at 51.41 on Wednesday.
Share market update: Most active stocks of the day in terms of total traded value (03-07-2024)
The NSE Nifty index was trading 149.31 points up at 24273.15
Vraj Iron and Steel shares list at 16% premium over IPO price (03-07-2024)
Vraj Iron and Steel's strong listing surge correlates with its exceptional 126.36 times subscription rate, reflecting robust investor confidence. Analysts highlight risks including regional facility concentration and absence of long-term customer contracts, advising cautious consideration amidst the company's promising outlook.
Share market update: Most active stocks on D-Street today in terms of volume (03-07-2024)
The NSE Nifty index was trading 153.21 points up at 24277.05
Stock market update: Nifty Pharma index advances 0.64% in an upbeat market (03-07-2024)
The Nifty Pharma index was trading 0.64 per cent up at 19913.35.
Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue? (03-07-2024)
Bansal Wire's IPO offers 2.19 crore shares, closing on July 5. Analysts recommend high-risk investors consider the IPO at a P/E ratio of 41.41x. The company plans to use funds for debt repayment, with a price band of Rs 243-256 per share.
These 4 stocks closed crossing above VWAP on July 2 (03-07-2024)
On July 2, the closing prices of four stocks in the Nifty500 pack rose by more than 1.5% compared to the Volume Weighted Average Price (VWAP).
These 4 stocks close crossing below VWAP on July 2 (03-07-2024)
On July 2, the closing prices of four stocks in the Nifty500 pack fell by more than 2% compared to the Volume Weighted Average Price (VWAP).
Add Coal India, target price Rs 495: ICICI Securities (03-07-2024)
Coal India Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 296488.86 Crore) operating in Mining sector.
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? (03-07-2024)
Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.